These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 10621945)

  • 1. Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer's disease.
    Harkany T; Hortobágyi T; Sasvári M; Kónya C; Penke B; Luiten PG; Nyakas C
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Aug; 23(6):963-1008. PubMed ID: 10621945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis.
    Harkany T; Abrahám I; Timmerman W; Laskay G; Tóth B; Sasvári M; Kónya C; Sebens JB; Korf J; Nyakas C; Zarándi M; Soós K; Penke B; Luiten PG
    Eur J Neurosci; 2000 Aug; 12(8):2735-45. PubMed ID: 10971616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: neuroprotection by Ca(2+) antagonist nimodipine.
    Harkany T; Dijkstra IM; Oosterink BJ; Horvath KM; Abrahám I; Keijser J; Van der Zee EA; Luiten PG
    Neuroscience; 2000; 101(1):101-14. PubMed ID: 11068140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
    Lipton SA
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer's disease.
    Arias C; Montiel T; Quiroz-Báez R; Massieu L
    Exp Neurol; 2002 Jul; 176(1):163-74. PubMed ID: 12093093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of beta-amyloid neurotoxicity: perspectives of pharmacotherapy.
    Harkany T; Abrahám I; Kónya C; Nyakas C; Zarándi M; Penke B; Luiten PG
    Rev Neurosci; 2000; 11(4):329-82. PubMed ID: 11065280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
    Lipton SA
    Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective mechanisms of adenosine in neurons and glial cells.
    Schubert P; Ogata T; Marchini C; Ferroni S; Rudolphi K
    Ann N Y Acad Sci; 1997 Oct; 825():1-10. PubMed ID: 9369970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
    Lipton SA; Gu Z; Nakamura T
    Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of free radical formation fail to attenuate direct beta-amyloid25-35 peptide-mediated neurotoxicity in rat hippocampal cultures.
    Lockhart BP; Benicourt C; Junien JL; Privat A
    J Neurosci Res; 1994 Nov; 39(4):494-505. PubMed ID: 7533847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological intervention in age-associated brain disorders by Flupirtine: Alzheimer's and prion diseases.
    Perovic S; Böhm M; Meesters E; Meinhardt A; Pergande G; Müller WE
    Mech Ageing Dev; 1998 Mar; 101(1-2):1-19. PubMed ID: 9593309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
    Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG
    Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide(25-35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease.
    Subramaniam R; Koppal T; Green M; Yatin S; Jordan B; Drake J; Butterfield DA
    Neurochem Res; 1998 Nov; 23(11):1403-10. PubMed ID: 9814551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimeric bis (heptyl)-Cognitin Blocks Alzheimer's β-Amyloid Neurotoxicity Via the Inhibition of Aβ Fibrils Formation and Disaggregation of Preformed Fibrils.
    Hu SQ; Wang R; Cui W; Mak SH; Li G; Hu YJ; Lee MY; Pang YP; Han YF
    CNS Neurosci Ther; 2015 Dec; 21(12):953-61. PubMed ID: 26507365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease.
    Rosini M; Simoni E; Caporaso R; Basagni F; Catanzaro M; Abu IF; Fagiani F; Fusco F; Masuzzo S; Albani D; Lanni C; Mellor IR; Minarini A
    Eur J Med Chem; 2019 Oct; 180():111-120. PubMed ID: 31301562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against β-amyloid neurotoxicity by a non-toxic endogenous N-terminal β-amyloid fragment and its active hexapeptide core sequence.
    Forest KH; Alfulaij N; Arora K; Taketa R; Sherrin T; Todorovic C; Lawrence JLM; Yoshikawa GT; Ng HL; Hruby VJ; Nichols RA
    J Neurochem; 2018 Jan; 144(2):201-217. PubMed ID: 29164616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.